Auvity S, Attili B, Caille F, Goislard M, Cayla J, Hinnen F
ACS Pharmacol Transl Sci. 2024; 7(10):3144-3154.
PMID: 39421654
PMC: 11480890.
DOI: 10.1021/acsptsci.4c00348.
Salerno S, Viviano M, Baglini E, Poggetti V, Giorgini D, Castagnoli J
Molecules. 2024; 29(17).
PMID: 39275061
PMC: 11397380.
DOI: 10.3390/molecules29174212.
Belov V, Guehl N, Duvvuri S, Iredale P, Moon S, Dhaynaut M
J Cereb Blood Flow Metab. 2024; 44(8):1329-1342.
PMID: 38477292
PMC: 11342722.
DOI: 10.1177/0271678X241238820.
Jiang H, Zhou C, Qiu L, Gropler R, Brier M, Wu G
ACS Chem Neurosci. 2023; 14(22):4039-4050.
PMID: 37882753
PMC: 11037862.
DOI: 10.1021/acschemneuro.3c00581.
Kitade M, Nakajima H, Tsujikawa T, Noriki S, Mori T, Kiyono Y
J Clin Med. 2023; 12(1).
PMID: 36614916
PMC: 9821277.
DOI: 10.3390/jcm12010116.
F-Radiolabeled Translocator Protein (TSPO) PET Tracers: Recent Development of TSPO Radioligands and Their Application to PET Study.
Luu T, Kim H
Pharmaceutics. 2022; 14(11).
PMID: 36432736
PMC: 9697781.
DOI: 10.3390/pharmaceutics14112545.
Essential Principles and Recent Progress in the Development of TSPO PET Ligands for Neuroinflammation Imaging.
Viviano M, Barresi E, Simeon F, Costa B, Taliani S, Da Settimo F
Curr Med Chem. 2022; 29(28):4862-4890.
PMID: 35352645
PMC: 10080361.
DOI: 10.2174/0929867329666220329204054.
Synthesis and Screening in Mice of Fluorine-Containing PET Radioligands for TSPO: Discovery of a Promising F-Labeled Ligand.
Simeon F, Lee J, Morse C, Stukes I, Zoghbi S, Manly L
J Med Chem. 2021; 64(22):16731-16745.
PMID: 34756026
PMC: 8817670.
DOI: 10.1021/acs.jmedchem.1c01562.
Direct Comparison of [F]F-DPA with [F]DPA-714 and [C]PBR28 for Neuroinflammation Imaging in the same Alzheimer's Disease Model Mice and Healthy Controls.
Lopez-Picon F, Keller T, Bocancea D, Helin J, Krzyczmonik A, Helin S
Mol Imaging Biol. 2021; 24(1):157-166.
PMID: 34542805
PMC: 8760190.
DOI: 10.1007/s11307-021-01646-5.
N-[F]-Fluoroacetylcrizotinib: A potentially potent and selective PET tracer for molecular imaging of non-small cell lung cancer.
Buck J, Saleh S, Claus T, Lovly C, Hight M, Nickels M
Bioorg Med Chem Lett. 2020; 30(16):127257.
PMID: 32631505
PMC: 7357882.
DOI: 10.1016/j.bmcl.2020.127257.
Methods to Enhance the Metabolic Stability of Peptide-Based PET Radiopharmaceuticals.
Evans B, King A, Katsifis A, Matesic L, Jamie J
Molecules. 2020; 25(10).
PMID: 32423178
PMC: 7287708.
DOI: 10.3390/molecules25102314.
Huntington's Disease: A Review of the Known PET Imaging Biomarkers and Targeting Radiotracers.
Cybulska K, Perk L, Booij J, Laverman P, Rijpkema M
Molecules. 2020; 25(3).
PMID: 31979301
PMC: 7038198.
DOI: 10.3390/molecules25030482.
The Current Role of Microfluidics in Radiofluorination Chemistry.
Knapp K, Nickels M, Manning H
Mol Imaging Biol. 2019; 22(3):463-475.
PMID: 31485889
DOI: 10.1007/s11307-019-01414-6.
characterization of a novel norepinephrine transporter PET tracer [F]NS12137 in adult and immature Sprague-Dawley rats.
Lopez-Picon F, Kirjavainen A, Forsback S, Takkinen J, Peters D, Haaparanta-Solin M
Theranostics. 2019; 9(1):11-19.
PMID: 30662550
PMC: 6332804.
DOI: 10.7150/thno.29740.
Monitoring the Progression of Chronic Liver Damage in Rats Using [F]PBR06.
Huang S, Li C, Guo J, Zhang L, Wu S, Wang H
Mol Imaging Biol. 2018; 21(4):669-675.
PMID: 30280292
DOI: 10.1007/s11307-018-1282-z.
TSPO-PET imaging using [18F]PBR06 is a potential translatable biomarker for treatment response in Huntington's disease: preclinical evidence with the p75NTR ligand LM11A-31.
Simmons D, James M, Belichenko N, Semaan S, Condon C, Kuan J
Hum Mol Genet. 2018; 27(16):2893-2912.
PMID: 29860333
PMC: 6077813.
DOI: 10.1093/hmg/ddy202.
Preclinical in vivo and in vitro comparison of the translocator protein PET ligands [F]PBR102 and [F]PBR111.
Eberl S, Katsifis A, Peyronneau M, Wen L, Henderson D, Loch C
Eur J Nucl Med Mol Imaging. 2016; 44(2):296-307.
PMID: 27699720
DOI: 10.1007/s00259-016-3517-z.
Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging.
Pike V
Curr Med Chem. 2016; 23(18):1818-69.
PMID: 27087244
PMC: 5579844.
DOI: 10.2174/0929867323666160418114826.
Methods to Increase the Metabolic Stability of (18)F-Radiotracers.
Kuchar M, Mamat C
Molecules. 2015; 20(9):16186-220.
PMID: 26404227
PMC: 6332123.
DOI: 10.3390/molecules200916186.
Synthesis and evaluation of translocator 18 kDa protein (TSPO) positron emission tomography (PET) radioligands with low binding sensitivity to human single nucleotide polymorphism rs6971.
Zanotti-Fregonara P, Zhang Y, Jenko K, Gladding R, Zoghbi S, Fujita M
ACS Chem Neurosci. 2014; 5(10):963-71.
PMID: 25123416
PMC: 4210126.
DOI: 10.1021/cn500138n.